News

Corticosteroid Rescue Therapy Can Replace Daily Use in Mild Asthma


 

FROM THE LANCET

Beclomethasone and the placebo inhalers were provided by Teva Pharmaceutical Industries, the manufacturer of a generic formulation of beclomethasone. Of the 20 coauthors, 12, including lead author Dr. Martinez, reported having been a board member and/or received consulting fees, honoraria, and/or pending grant support from various pharmaceutical companies, including AstraZeneca, GlaxoSmithKline, MedImmune, and Merck. The remaining authors had no disclosures.

Pages

Recommended Reading

Bronchiolitis Diagnosis and Treatment Still Difficult
MDedge Internal Medicine
Ipilimumab Shows Modest Activity in Advanced NSCLC
MDedge Internal Medicine
Age Is Associated With Mortality Risk in ICU Patients With Pneumonia
MDedge Internal Medicine
Shirodhara: Alternative Treatment for Insomnia Studied
MDedge Internal Medicine
Less Treatment May Be Better in Pulmonary Sarcoidosis
MDedge Internal Medicine
COPD in Acute MI Patients Spells Trouble
MDedge Internal Medicine
Pulmonary Embolism Treatment Often Lags
MDedge Internal Medicine
Study Supports Broader Use of Rib Fixation in Flail Chest
MDedge Internal Medicine
New Fungal Infection Guidelines Include Novel Agents
MDedge Internal Medicine
Many Children With RLS Have Psychiatric Comorbidities
MDedge Internal Medicine